Aoyama Zaisan Networks Company,Limited Logo

Aoyama Zaisan Networks Company,Limited

Consulting on inheritance and business succession for individuals and corporations.

8929 | T

Overview

Corporate Details

ISIN(s):
JP3825750007
LEI:
Country:
Japan
Address:
港区赤坂八丁目4番14号青山タワープレイス3階
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Aoyama Zaisan Networks Company, Limited is a Japanese consulting firm specializing in comprehensive property and asset management solutions. The company primarily offers two types of services: inheritance consulting for individual asset owners and business succession consulting for corporations. It leverages its expertise in real estate, financial products, and related services to provide tailored solutions for asset transfer, maintenance, and operations. The firm's service portfolio also includes real estate solutions and property investment support in the USA.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-07 08:32
Report Publication Announcement
確認書
Japanese 8.1 KB
2025-08-07 08:31
Interim Report
半期報告書-第35期(2025/01/01-2025/12/31)
Japanese 201.7 KB
2025-06-11 06:18
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 24.3 KB
2025-05-09 05:53
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 21.7 KB
2025-04-07 03:24
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 21.7 KB
2025-03-27 07:51
Registration Form
確認書
Japanese 8.2 KB
2025-03-27 07:51
Governance Information
内部統制報告書-第34期(2024/01/01-2024/12/31)
Japanese 22.0 KB
2025-03-27 07:50
Annual Report
有価証券報告書-第34期(2024/01/01-2024/12/31)
Japanese 2.0 MB
2025-03-27 07:46
Post-Annual General Meeting Information
臨時報告書
Japanese 23.4 KB
2025-03-10 08:44
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 21.7 KB
2025-02-10 07:56
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 21.7 KB
2025-01-15 08:52
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 24.1 KB
2024-12-12 06:15
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 22.9 KB
2024-11-14 08:01
M&A Activity
臨時報告書
Japanese 64.0 KB
2024-08-08 08:03
Report Publication Announcement
確認書
Japanese 8.1 KB

Automate Your Workflow. Get a real-time feed of all Aoyama Zaisan Networks Company,Limited filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Aoyama Zaisan Networks Company,Limited

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Aoyama Zaisan Networks Company,Limited via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Eezy Oyj Logo
HR services firm for the full employment lifecycle, from recruitment to freelancer support.
Finland
EEZY
Elicio Therapeutics, Inc. Logo
Develops lymph node-targeted immunotherapies for aggressive, KRAS-driven cancers.
United States of America
ELTX
enCore Energy Corp. Logo
American uranium producer using ISR technology to fuel the U.S. nuclear energy sector.
United States of America
EU
ENERGY FUELS INC Logo
A leading U.S. producer of uranium and rare earth elements for EVs, defense, and technology.
United States of America
UUUU
ENIGMATIG LTD Logo
Global expansion and regulatory compliance consultancy for the financial services industry.
United States of America
EGG
Enjin Co., Ltd. Logo
PR firm for SMEs and medical institutions, offering consulting and a media matching platform.
Japan
7370
Ensol Biosciences Inc. Logo
Develops AI-discovered peptide drugs for cancer, osteoarthritis, and Alzheimer's disease.
South Korea
140610
Enveric Biosciences, Inc. Logo
Develops novel neuroplastogen drugs for severe mental health and addiction disorders.
United States of America
ENVB
Eutilex Co.,Ltd. Logo
Develops T-cell and antibody immunotherapies for cancer and autoimmune diseases.
South Korea
263050
Evaxion A/S Logo
Develops AI-powered, personalized vaccines for cancer and infectious diseases.
United States of America
EVAX

Talk to a Data Expert

Have a question? We'll get back to you promptly.